Diabetes: Intensive Insulin Protocol Implementation and Outcomes in the Medical and Surgical Wards at a Veterans Affairs Medical Center

Abstract

Spanish

French

Background:

Hyperglycemia is an important marker for clinical outcomes and mortality in hospitalized patients. New national standards have been established emphasizing the importance of improving inpatient glycemic control in individuals with diabetes or new-onset hyperglycemia. Implementation of these new standards is complex and requires a multidisciplinary team approach. A basal-bolus insulin regimen approach has been shown to improve inpatient glycemic control. Few studies have been published regarding basal-bolus insulin protocol outcomes in the non–intensive care unit (ICU) setting.

Objective:

To evaluate the efficacy of a basal-bolus insulin protocol on inpatient glycemic control in a non-ICU setting, as measured by mean blood glucose and number of hypoglycemic episodes per patient admission.

Methods:

A retrospective, observational, single-center study was conducted to compare blood glucose control pre- (October 2006–March 2007) and postprotocol (November 2007–January 2008) implementation. Inclusion criteria consisted of patient admission to a medical or surgical ward for at least 72 hours, with a diagnosis of diabetes, or presentation with 2 blood glucose readings greater than 180 mg/dL. Patients admitted to the ICU or those not admitted to a medical or surgical ward were excluded.

Results:

Following protocol implementation, the mean ± SD blood glucose level increased from 174 ± 88 mg/dL to 188 ± 95 mg/dL (p < 0.001) and the hypoglycemic incidents significantly decreased, from 1.11 to 0.51 events per patient admission (p < 0.0025).

Conclusions:

In this pilot study, implementation of a basal-bolus insulin protocol significantly reduced hypoglycemic events; however, mean blood glucose values increased. These results suggest that a basal-bolus insulin protocol can reduce hypoglycemia; however, factors such as protocol compliance, barriers in overcoming the use of the traditional sliding scale insulin regimens, staff education, and change of work-flow habits can influence the overall efficacy and impact of a basal-bolus insulin protocol on inpatient gtycemic control.

Keywords

blood glucose clinical protocols diabetes mellitus insulin

Get full access to this article

View all access options for this article.

References

DeFrances

, Podgornik

. 2004 National Hospital Discharge Survey. Advance data from vital health statistics; No. 371. Hyattsville, MD: National Center for Health Statistics, 2006.

Cowie

, Rust

, Ford

. Full accounting of diabetes and prediabetes in the US population in 1988–1994 and 2005–2006. Diabetes Care 2009; 32:287–94.

Brietzke

, Gardner

. Inpatient management of diabetes. Hosp Physician 2009; 7:2–12.

Moghissi

, Korytkowski

, DiNardo

. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 2009; 15:353–69.

Capes

, Hunt

, Malmberg

, Gerstein

. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systemic overview. Lancet 2000; 355:773–8.

Capes

, Hunt

, Malmberg

, Pathak

, Gerstein

. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systemic overview. Stroke 2001; 32:2426–32.

Umpierrez

, Isaacs

, Bazargan

. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87:978–82.

Baldwin

, Villaneuva

, McNutt

, Bhatnager

. Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. Diabetes Care 2005; 28:1008–11.

Donihi

, DiNardo

, DeVita

, Korytkowski

. Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin. Qual Saf Health Care 2006; 15:89–91.

10.

Umpierrez

, Smiley

, Zisman

. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 Trial). Diabetes Care 2007; 30:2181–6.

11.

Van den Berghe

, Wouters

, Weekers

. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359–67.

12.

Pittas

, Siegel

, Lau

. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2004; 164:2005–11.

13.

Van den Berghe

, Wilmer

, Hermans

. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449–61.

14.

Reed

, Stewart

, Sherman

. Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. J Am Coll Surg 2007; 204:1048–54.

15.

The NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283–97.

16.

Irizucchi

, Siegel

. Glucose control in the ICU–-how tight is too tight? N Engl J Med 2009; 360:1346–8.

17.

The AACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control: a call to action. Diabetes Care 2006; 29:1955–62.

18.

Newton

, Young

. Financial implications of glycemic control: results of an inpatient diabetes management program. Endocr Pract 2006; 12(suppl 3):43–8.

19.

Reynolds

, Cook

, Lewis

. An institutional process to improve inpatient glycemic control. Q Manage Health Care 2007; 16:239–49.

20.

Umpierrez

, Palacio

, Smiley

. Sliding scale insulin use: myth or insanity? Am J Med 2007; 120:563–7.